Fluarix 2025/2026 58160-0912
Generic: Influenza Virus Vaccine
Product NDC
58160-0912- Manufacturer
- Glaxosmithkline Biologicals Sa
- Dosage Form
- Suspension
- Route
- Intramuscular
- Product Type
- Vaccine
- Marketing Start
- July 1, 2025
- Application
- BLA125127
Active Ingredients
| Ingredient | Strength |
|---|---|
| Influenza A Virus A/thailand/8/2022 Ivr-237 (h3n2) Antigen (formaldehyde Inactivated) | 15 ug/.5mL |
| Influenza A Virus A/victoria/4897/2022 Ivr-238 (h1n1) Antigen (formaldehyde Inactivated) | 15 ug/.5mL |
| Influenza B Virus B/austria/1359417/2021 Bvr-26 Antigen (formaldehyde Inactivated) | 15 ug/.5mL |
Packaging Options(1)
10 SYRINGE in 1 CARTON (58160-912-52) / .5 mL in 1 SYRINGE (58160-912-41)